CIK 0002088082 · <br>Emerging growth company
Electra Therapeutics, Inc.
Sign in to watch- Ticker
- ETRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832193635
- Phone
- (888) 743-2290
- Business address
- 230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $48,699,284
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$48,699,284. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +9,267 | $7.78 | $72K | 5,184,871 |
| 2026-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +37,100 | $7.78 | $289K | 1,991,779 |
| 2026-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +5,000 | $7.07 | $35K | 5,189,871 |
| 2026-11-04 | ORBIMED ADVISORS LLC Director | Purchase | +20,000 | $7.07 | $141K | 2,011,779 |
| 2026-11-03 | GORDON CARL L Director | Purchase | +24,313 | $7.84 | $191K | 5,151,204 |
| 2026-11-03 | GORDON CARL L Director | Purchase | +97,800 | $7.84 | $767K | 1,856,079 |
| 2026-11-03 | GORDON CARL L Director | Purchase | +24,400 | $7.88 | $192K | 5,175,604 |
| 2026-11-03 | GORDON CARL L Director | Purchase | +98,600 | $7.88 | $777K | 1,954,679 |
| 2026-11-03 | ORBIMED ADVISORS LLC Director | Purchase | +24,313 | $7.84 | $191K | 5,151,204 |
| 2026-11-03 | ORBIMED ADVISORS LLC Director | Purchase | +97,800 | $7.84 | $767K | 1,856,079 |
| 2026-11-03 | ORBIMED ADVISORS LLC Director | Purchase | +24,400 | $7.88 | $192K | 5,175,604 |
| 2026-11-03 | ORBIMED ADVISORS LLC Director | Purchase | +98,600 | $7.88 | $777K | 1,954,679 |
| 2026-09-21 | GORDON CARL L Director | Conversion | +2,002,310 | 2,002,310 | ||
| 2026-09-21 | GORDON CARL L Director | Conversion | +1,087,934 | 3,090,244 | ||
| 2026-09-21 | GORDON CARL L Director | Conversion | +1,703,314 | 4,793,558 | ||
| 2026-09-21 | GORDON CARL L Director | Purchase | +333,333 | $15.00 | $5.0M | 5,126,891 |
| 2026-09-21 | GORDON CARL L Director | Conversion | +758,279 | 758,279 | ||
| 2026-09-21 | GORDON CARL L Director | Purchase | +1,000,000 | $15.00 | $15.0M | 1,758,279 |
| 2026-09-21 | GORDON CARL L Director | Conversion · Series A Convertible Preferred Stock | −2,002,310 | 0 | ||
| 2026-09-21 | GORDON CARL L Director | Conversion · Series B Convertible Preferred Stock | −1,087,934 | 0 |
Page 2 of 3 · 60 trades